99% Savings - Buy Just @1 Rs X
Enapril 5 Tablet is a prescription medicine that is available as a Tablet. High BP are some of its major therapeutic uses. Other than this, Enapril 5 Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Enapril 5 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Enapril 5 Tablet as well, which are listed below. Such side effects of Enapril 5 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Enapril 5 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Enapril 5 Tablet's effects on the liver, heart and kidney are discussed below in the Enapril 5 Tablet related warnings section.
Enapril 5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema, Low Blood Pressure (Hypotension) are examples of such conditions. Other contraindications of Enapril 5 Tablet have been discussed in the sections ahead.
Additionally, Enapril 5 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Enapril 5 Tablet is not safe while driving, and is not addiction.
Enapril 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Enapril 5 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Enapril Tablet. If you are pregnant, do not take Enapril Tablet without a doctor's advice.
Is the use of Enapril 5 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Enapril Tablet. So it is adviced to consult the doctor before using it.
What is the effect of Enapril 5 Tablet on the Kidneys?
Enapril Tablet has very mild side effects on the kidneys.
What is the effect of Enapril 5 Tablet on the Liver?
Enapril Tablet is rarely harmful for the liver.
What is the effect of Enapril 5 Tablet on the Heart?
Very few cases of side effects of Enapril Tablet on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Enapril 5 Tablet unless your doctor advises you to do so -
Is this Enapril 5 Tablet habit forming or addictive?
No, you will not get addicted to Enapril 5 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Enapril 5 Tablet as you may feel sleepy.
Is it safe?
Yes, Enapril 5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Enapril 5 Tablet in mental disorders is not effective.
Interaction between Food and Enapril 5 Tablet
Enapril 5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Enapril 5 Tablet
It is difficult to say anything about the effect of Enapril 5 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epaned (enalapril maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 502-503